KR100309754B1 - 벤젠유도체및이를함유하는약제학적조성물 - Google Patents

벤젠유도체및이를함유하는약제학적조성물 Download PDF

Info

Publication number
KR100309754B1
KR100309754B1 KR1019970705095A KR19970705095A KR100309754B1 KR 100309754 B1 KR100309754 B1 KR 100309754B1 KR 1019970705095 A KR1019970705095 A KR 1019970705095A KR 19970705095 A KR19970705095 A KR 19970705095A KR 100309754 B1 KR100309754 B1 KR 100309754B1
Authority
KR
South Korea
Prior art keywords
group
formula
methyl
hydrogen atom
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019970705095A
Other languages
English (en)
Korean (ko)
Other versions
KR19980701699A (ko
Inventor
마사이치 하세가와
다쿠미 다케야스
나오키 쓰치야
나오키 하세
가쓰시 다카하시
다카시 가미무라
Original Assignee
야스이 쇼사꾸
데이진 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야스이 쇼사꾸, 데이진 가부시키가이샤 filed Critical 야스이 쇼사꾸
Publication of KR19980701699A publication Critical patent/KR19980701699A/ko
Application granted granted Critical
Publication of KR100309754B1 publication Critical patent/KR100309754B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019970705095A 1995-11-27 1996-11-26 벤젠유도체및이를함유하는약제학적조성물 Expired - Fee Related KR100309754B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30722295 1995-11-27
JP95-307222 1995-11-27
JP22836796 1996-08-29
JP96-228367 1996-08-29
PCT/JP1996/003456 WO1997019910A1 (en) 1995-11-27 1996-11-26 Benzene derivatives

Publications (2)

Publication Number Publication Date
KR19980701699A KR19980701699A (ko) 1998-06-25
KR100309754B1 true KR100309754B1 (ko) 2002-05-30

Family

ID=26528211

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970705095A Expired - Fee Related KR100309754B1 (ko) 1995-11-27 1996-11-26 벤젠유도체및이를함유하는약제학적조성물

Country Status (12)

Country Link
US (1) US5808144A (enExample)
EP (1) EP0806412B1 (enExample)
JP (1) JP3117466B2 (enExample)
KR (1) KR100309754B1 (enExample)
CN (1) CN1081623C (enExample)
AT (1) ATE191458T1 (enExample)
AU (1) AU703092B2 (enExample)
CA (1) CA2210579C (enExample)
DE (1) DE69607597T2 (enExample)
ES (1) ES2144786T3 (enExample)
TW (1) TW346483B (enExample)
WO (1) WO1997019910A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649656B1 (en) * 1998-07-24 2003-11-18 Teijin Limited Anthranilic acid derivatives
US6627743B1 (en) * 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
AU2001234089B2 (en) * 2000-02-15 2005-08-11 Teijin Limited Cancer remedy comprising anthranilic acid derivative as active ingredient
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
WO2020252195A1 (en) * 2019-06-11 2020-12-17 The Wistar Institute Of Anatomy And Biology Telomerase reverse transcriptase degraders and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE736787A (fr) * 1968-08-02 1970-01-30 Roussel Uclaf Dérivés de l'acide anthranilique et procédé de préparation
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
WO1993015043A1 (fr) 1992-01-24 1993-08-05 Yoshitomi Pharmaceutical Industries, Ltd. Compose arylalkananilide et utilisation pharmaceutique
US5783593A (en) * 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase

Also Published As

Publication number Publication date
ATE191458T1 (de) 2000-04-15
US5808144A (en) 1998-09-15
CN1081623C (zh) 2002-03-27
DE69607597T2 (de) 2000-08-24
AU7590296A (en) 1997-06-19
EP0806412B1 (en) 2000-04-05
EP0806412A1 (en) 1997-11-12
KR19980701699A (ko) 1998-06-25
CA2210579A1 (en) 1997-06-05
WO1997019910A1 (en) 1997-06-05
EP0806412A4 (enExample) 1997-11-12
CA2210579C (en) 2003-03-11
ES2144786T3 (es) 2000-06-16
CN1173169A (zh) 1998-02-11
TW346483B (en) 1998-12-01
JP3117466B2 (ja) 2000-12-11
AU703092B2 (en) 1999-03-18
DE69607597D1 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
JP3894949B2 (ja) 抗アテローム性動脈硬化症ジアリール化合物
JPH06759B2 (ja) 新規なベンゾイミダゾール化合物
EP0288189A1 (en) Improvements in or relating to leukotriene antagonists
CZ295618B6 (cs) Pyrazinové deriváty, způsob výroby a farmaceutický prostředek
DE69512777T2 (de) Naphthalinderivate
WO1991001306A1 (en) Oxoindole derivative
JPH0912560A (ja) 改良された抗ウイルス化合物
JPWO1998004508A1 (ja) 新規パラテルフェニル化合物
JPWO1995032943A1 (ja) ナフタレン誘導体
EP0812831B1 (en) Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
JPH1160557A (ja) アポb分泌/mtp阻害剤の塩酸塩
CN1142227A (zh) 新的噻唑烷-4-酮衍生物
JPS63107958A (ja) 新規なシクロオキシゲナ−ゼおよびリポキシゲナ−ゼ複合阻害剤
CZ8297A3 (en) Benzamidine, process of its preparation and pharmaceutical compositions containing thereof
JPH0717589B2 (ja) 新規1,3―ジカルボニル化合物およびその組成物
JPS5920266A (ja) 乾癬治療に便利なアルフア−ポリオレフイン性カルボン酸とそれらの誘導体
JP3117466B2 (ja) ベンゼン誘導体
JPWO1997019910A1 (ja) ベンゼン誘導体
KR100355096B1 (ko) 신규푸린유도체및그약학적으로허용되는염
JP3265134B2 (ja) 含窒素二環性複素環誘導体およびこれを含有する医薬製剤
JP3468729B2 (ja) 5−リポキシゲナーゼ阻害剤を製造するための方法及び中間体
JPS63284170A (ja) 新規グアニジノメチル−チオフエンカルボン酸誘導体
KR890004662B1 (ko) 1,8-나프티리딘과 1,5,8-아자나프티리딘 유도체 및 이의 제조방법
JPH02115182A (ja) 光学活性ピリドンカルボン酸化合物
JPH03148276A (ja) 光学活性なピリドンカルボン酸化合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20070903

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20080912

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20080912

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000